Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $305.9M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -7%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $894.2M covers the $160.0M due within a year 5.6× over. Scheduled principal only (excludes interest & revolver draws). As of 2020-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~7.6% on $8.68B of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.44B 100.0% | $4.45B 100.0% | $4.51B 100.0% | $4.81B 100.0% | $4.81B 100.0% | $3.78B 100.0% | $3.87B 100.0% | $3.71B 100.0% | $3.59B 100.0% | $2.72B 100.0% |
| Cost of Revenue | $975.9M 22.0% | $989.4M 22.2% | $1.02B 22.6% | $1.21B 25.2% | $1.21B 25.2% | $860.4M 22.7% | $877.8M 22.7% | $877.2M 23.7% | $876.2M 24.4% | — |
| Cost of Services | — | — | — | — | — | — | — | $889.8M 24.0% | $876.2M 24.4% | $677.2M 24.9% |
| Selling, General & Admin | $179.6M 4.0% | $189.6M 4.3% | $181.1M 4.0% | $226.0M 4.7% | $229.4M 4.8% | $168.1M 4.4% | $803.3M 20.8% | $768.2M 20.7% | $710.7M 19.8% | $521.6M 19.1% |
| Total Operating Expenses | $4.33B 97.6% | $4.52B 101.7% | $3.99B 88.5% | $4.72B 98.2% | $4.75B 98.7% | $3.70B 97.7% | $3.54B 91.6% | $3.73B 100.6% | $3.75B 104.5% | $2.41B 88.4% |
| Operating Income | $108.2M 2.4% | -$76.8M -1.7% | $517.7M 11.5% | $86.5M 1.8% | $63.8M 1.3% | $86.7M 2.3% | $325.8M 8.4% | -$23.6M -0.6% | -$162.9M -4.5% | $315.3M 11.6% |
| Interest Expense | $656.4M 14.8% | $627.7M 14.1% | $601.7M 13.3% | $556.7M 11.6% | $527.4M 11.0% | $533.4M 14.1% | $499.2M 12.9% | $443.7M 12.0% | $381.8M 10.6% | $314.4M 11.5% |
| Other Income (Expense), net | -$761.0M -17.1% | -$583.1M -13.1% | -$580.1M -12.9% | -$209.5M -4.4% | -$381.8M -7.9% | -$924.9M -24.5% | -$634.4M -16.4% | -$561.1M -15.1% | -$488.3M -13.6% | -$413.4M -15.2% |
| Pretax Income | -$652.8M -14.7% | -$659.9M -14.8% | -$62.4M -1.4% | -$123.0M -2.6% | -$318.0M -6.6% | -$838.2M -22.2% | -$308.6M -8.0% | -$584.7M -15.8% | -$651.2M -18.1% | -$98.1M -3.6% |
| Income Tax Expense | -$98.5M -2.2% | -$200K -0.0% | $24.4M 0.5% | $84.8M 1.8% | $172.6M 3.6% | -$29.2M -0.8% | -$100.2M -2.6% | $51.1M 1.4% | $147.5M 4.1% | $305.9M 11.2% |
| Net Income | -$611.2M -13.8% | -$689.4M -15.5% | -$73.6M -1.6% | -$170.7M -3.5% | -$440.6M -9.2% | -$687.3M -18.2% | -$106.1M -2.7% | -$345.2M -9.3% | -$778.1M -21.7% | -$432.3M -15.9% |
| Per Share | ||||||||||
| EPS (Basic) | -$3.06 | -$3.47 | -$0.35 | -$0.77 | -$1.89 | -$3.51 | -$0.58 | — | — | — |
| EPS (Diluted) | -$3.06 | -$3.47 | -$0.35 | -$0.77 | -$1.89 | -$3.51 | -$0.58 | — | — | — |
| Weighted Avg Shares (Basic) | 199.5M | 198.4M | 210.0M | 222.6M | 232.6M | 195.5M | 184.4M | — | — | — |
| Weighted Avg Shares (Diluted) | 199.5M | 198.4M | 210.0M | 222.6M | 232.6M | 195.5M | 184.4M | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-30 | 2 co-filers Group filing | Grant | 102 | $8.28 | $845 |
| 2026-09-30 | 2 co-filers Group filing | Grant | 1,229 | $8.28 | $10k |
| 2026-09-30 | 2 co-filers Group filing | Grant | 1,163 | $8.28 | $10k |
| 2026-09-30 | 2 co-filers Group filing | Grant |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| 205 |
| $8.22 |
| $2k |
| 2026-09-30 | 2 co-filers Group filing | Grant | 2,326 | $8.22 | $19k |
| 2026-09-30 | 3 co-filers Group filing | Open-market buyindirect | 1,013 | $20.43 | $21k |
| 2026-09-30 | 2 co-filers Group filing | Grant | 2,457 | $8.22 | $20k |
| 2026-09-30 | 3 co-filers Group filing | Open-market buyindirect | 20,000 | $8.40 | $168k |
| 2026-09-29 | 3 co-filers Group filing | Open-market buyindirect | 512 | $20.45 | $10k |
| 2026-09-28 | 3 co-filers Group filing | Open-market buyindirect | 7,945 | $20.43 | $162k |
| 2026-09-25 | 3 co-filers Group filing | Open-market buyindirect | 13,362 | $20.44 | $273k |
| 2026-09-24 | 3 co-filers Group filing | Open-market buyindirect | 1,135 | $20.45 | $23k |
| 2026-09-17 | 2 co-filers Group filing | Open-market buyindirect | 168 | $20.44 | $3k |
| 2026-09-16 | 2 co-filers Group filing | Open-market buyindirect | 36,914 | $20.43 | $754k |
| 2026-09-02 | 3 co-filers Group filing | Open-market buyindirect | 313,104 | $20.95 | $6.6m |
| 2026-09-01 | 3 co-filers Group filing | Open-market buyindirect | 17,596 | $20.65 | $363k |
| 2026-09-01 | 2 co-filers Group filing | Open-market buyindirect | 69,454 | $8.50 | $590k |
| 2026-08-31 | 3 co-filers Group filing | Open-market buyindirect | 145,490 | $21.00 | $3.1m |
| 2026-08-28 | 2 co-filers Group filing | Open-market buyindirect | 51,832 | $8.48 | $439k |
| 2026-08-14 | Malone John C 10% owner | Open-market buyindirect | 6,761 | $8.50 | $57k |
| 2026-08-13 | 2 co-filers Group filing | Open-market buyindirect | 28,219 | $8.50 | $240k |
| 2026-08-11 | 2 co-filers Group filing | Open-market buyindirect | 22,477 | $8.50 | $191k |
| 2026-08-11 | 2 co-filers Group filing | Open-market saleindirect | 42,975 | $8.57 | $368k |
| 2026-08-11 | 2 co-filers Group filing | Open-market buyindirect | 17,425 | $20.93 | $365k |
| 2026-08-10 | 4 co-filers Group filing | Open-market buyindirect | 97,955 | $8.47 | $830k |
| 2026-08-10 | 4 co-filers Group filing | Open-market buyindirect | 15,749 | $20.40 | $321k |
| 2026-08-07 | 4 co-filers Group filing | Open-market buyindirect | 29,873 | $8.50 | $254k |
| 2026-08-07 | 4 co-filers Group filing | Open-market buyindirect | 73,455 | $20.42 | $1.5m |
| 2026-06-30 | 5 co-filers SVP, CHIEF FINANCIAL OFFICER | Grant29d late | 833 | $0.00 | $0 |
| 2026-06-30 | 2 co-filers Group filing | Grant | 1,227 | $7.84 | $10k |
| 2026-06-30 | 3 co-filers SVP, CT&PO | Grant29d late | 833 | $0.00 | $0 |
| 2026-06-30 | 2 co-filers Group filing | Grant | 108 | $7.84 | $847 |
| 2026-06-30 | 2 co-filers Group filing | Grant | 1,298 | $7.84 | $10k |
| 2026-06-30 | 5 co-filers SVP, CLO AND SECRETARY | Grant29d late | 663 | $0.00 | $0 |
| 2026-06-30 | 5 co-filers President and CEO | Grant29d late | 803 | $0.00 | $0 |
| 2026-06-30 | 2 co-filers Group filing | Grant | 2,455 | $7.79 | $19k |
| 2026-06-30 | 5 co-filers SVP, CHIEF FINANCIAL OFFICER | Tax withholding29d late | 658 | $7.79 | $5k |
| 2026-06-30 | 5 co-filers SVP, CLO AND SECRETARY | Tax withholding29d late | 371 | $7.79 | $3k |
| 2026-06-30 | 3 co-filers SVP, CT&PO | Grant29d late | 2,500 | $7.32 | $18k |
| 2026-06-30 | 5 co-filers President and CEO | Tax withholding29d late | 449 | $7.79 | $3k |
No current price collected.
Where each multiple sits in its own 11-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 11-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE -110% against ROIC -7% — -103% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is -74.3% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 23.7 | 22.7 | 22.7 | 25.2 | 25.2 | 22.6 | 22.2 | 22.0 |
| SG&A | 20.7 | 20.8 | 4.4 | 4.8 | 4.7 | 4.0 | 4.3 | 4.0 |
| Operating Income | -0.6 | 8.4 | 2.3 | 1.3 | 1.8 | 11.5 | -1.7 | 2.4 |
| Income Tax | 1.4 | -2.6 | -0.8 | 3.6 | 1.8 | 0.5 | -0.0 | -2.2 |
| Net Income | -9.3 | -2.7 | -18.2 | -9.2 | -3.5 | -1.6 | -15.5 | -13.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on LILAB: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Cost of capital cannot be computed, so the spread is unknown.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | not reported | 11.6% | -15.9% |
| FY2017 | 75.6% | -4.5% | -21.7% |
| FY2018 | 76.3% | -0.6% | -9.3% |
| FY2019 | 77.3% | 8.4% | -2.7% |
| FY2020 | 77.3% | 2.3% | -18.2% |
| FY2021 | 74.8% | 1.3% | -9.2% |
| FY2022 | 74.8% | 1.8% | -3.5% |
| FY2023 | 77.4% | 11.5% | -1.6% |
| FY2024 | 77.8% | -1.7% | -15.5% |
| FY2025 | 78.0% | 2.4% | -13.8% |
Return on equity is 103 points BELOW the return on invested capital, which means the equity base is carrying capital the operations are not earning on — usually cash, goodwill, or a recent raise.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: beta, tax_rate, market_cap.
Fewer than three profitable years with a cash flow statement, so cash conversion cannot be judged.
No material counter-signal in the checked set: FCF / net income over 3 and 5 years, Sloan accruals, SBC as a share of revenue, SBC as a share of operating cash flow, SBC-adjusted free cash flow, free cash flow per diluted share, buybacks against SBC issued, capex vs depreciation, free cash flow against revenue, share count since the first year on file, cash conversion cycle (DSO, DIO, DPO), receivables growth against revenue growth.
Missing from our data, so excluded from this answer: 3 years of cash flow.
Debt is present but there is no positive EBITDA or no reported interest expense, so coverage cannot be measured.
This schedule comes from a filing dated 2020-12-31, 2130 days old. Maturities are shown relative to that date, not to today.
Ladder as of 2020-12-31 (10-K); cash from the 2020-12-31 balance sheet; FCF from FY2020.
Balance sheet at 2020-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
Missing from our data, so excluded from this answer: interest_expense.
No current price or share count, so the market's assumption cannot be solved for.
No material counter-signal in the checked set: reverse-DCF implied growth, historical FCF CAGR, per-year FCF growth distribution, reporting-basis breaks, discount rate used, free-cash-flow basis (stock comp charged?).
Missing from our data, so excluded from this answer: market_cap.